Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fiasp versus NovoRapid during exercise with reduced prandial insulin dosing in type 1 diabetes
2019-001281-14Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of human insulin and insulin aspart in diabetes mellitus type 1 (T1D) (4 arms), sponsored by Medical University of Graz. Started May 2019; status: completed.
02
Drugs
human insulininsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2019-001281-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001281-14.